BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 35076017)

  • 1. iMyoblasts for ex vivo and in vivo investigations of human myogenesis and disease modeling.
    Guo D; Daman K; Chen JJ; Shi MJ; Yan J; Matijasevic Z; Rickard AM; Bennett MH; Kiselyov A; Zhou H; Bang AG; Wagner KR; Maehr R; King OD; Hayward LJ; Emerson CP
    Elife; 2022 Jan; 11():. PubMed ID: 35076017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression patterns of FSHD-causing DUX4 and myogenic transcription factors PAX3 and PAX7 are spatially distinct in differentiating human stem cell cultures.
    Haynes P; Kernan K; Zhou SL; Miller DG
    Skelet Muscle; 2017 Jun; 7(1):13. PubMed ID: 28637492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of iMyoblasts from Human Induced Pluripotent Stem Cells.
    Guo D; Daman K; Durso DF; Yan J; Emerson CP
    Bio Protoc; 2022 Sep; 12(17):. PubMed ID: 36213105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induced Fetal Human Muscle Stem Cells with High Therapeutic Potential in a Mouse Muscular Dystrophy Model.
    Zhao M; Tazumi A; Takayama S; Takenaka-Ninagawa N; Nalbandian M; Nagai M; Nakamura Y; Nakasa M; Watanabe A; Ikeya M; Hotta A; Ito Y; Sato T; Sakurai H
    Stem Cell Reports; 2020 Jul; 15(1):80-94. PubMed ID: 32619494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human skeletal muscle organoids model fetal myogenesis and sustain uncommitted PAX7 myogenic progenitors.
    Mavrommatis L; Jeong HW; Kindler U; Gomez-Giro G; Kienitz MC; Stehling M; Psathaki OE; Zeuschner D; Bixel MG; Han D; Morosan-Puopolo G; Gerovska D; Yang JH; Kim JB; Arauzo-Bravo MJ; Schwamborn JC; Hahn SA; Adams RH; Schöler HR; Vorgerd M; Brand-Saberi B; Zaehres H
    Elife; 2023 Nov; 12():. PubMed ID: 37963071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression during normal and FSHD myogenesis.
    Tsumagari K; Chang SC; Lacey M; Baribault C; Chittur SV; Sowden J; Tawil R; Crawford GE; Ehrlich M
    BMC Med Genomics; 2011 Sep; 4():67. PubMed ID: 21951698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pluripotent stem cell-derived myogenic progenitors remodel their molecular signature upon in vivo engraftment.
    Incitti T; Magli A; Darabi R; Yuan C; Lin K; Arpke RW; Azzag K; Yamamoto A; Stewart R; Thomson JA; Kyba M; Perlingeiro RCR
    Proc Natl Acad Sci U S A; 2019 Mar; 116(10):4346-4351. PubMed ID: 30760602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The possible place of autologus cell therapy in facioscapulohumeral muscular dystrophy].
    Desnuelle C; Sacconi S; Marolleau JP; Larghero J; Vilquin JT
    Bull Acad Natl Med; 2005 Apr; 189(4):697-713; discussion 713-4. PubMed ID: 16245686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myogenic differentiation of muscular dystrophy-specific induced pluripotent stem cells for use in drug discovery.
    Abujarour R; Bennett M; Valamehr B; Lee TT; Robinson M; Robbins D; Le T; Lai K; Flynn P
    Stem Cells Transl Med; 2014 Feb; 3(2):149-60. PubMed ID: 24396035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ret function in muscle stem cells points to tyrosine kinase inhibitor therapy for facioscapulohumeral muscular dystrophy.
    Moyle LA; Blanc E; Jaka O; Prueller J; Banerji CR; Tedesco FS; Harridge SD; Knight RD; Zammit PS
    Elife; 2016 Nov; 5():. PubMed ID: 27841748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skeletal muscle regeneration in facioscapulohumeral muscular dystrophy is correlated with pathological severity.
    Banerji CRS; Henderson D; Tawil RN; Zammit PS
    Hum Mol Genet; 2020 Sep; 29(16):2746-2760. PubMed ID: 32744322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of CCAAT/Enhancer-Binding Protein β Expression With the Phosphodiesterase Inhibitor Isobutylmethylxanthine Improves Myoblast Engraftment Into Dystrophic Muscle.
    Lala-Tabbert N; Fu D; Wiper-Bergeron N
    Stem Cells Transl Med; 2016 Apr; 5(4):500-10. PubMed ID: 26941360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear bodies reorganize during myogenesis in vitro and are differentially disrupted by expression of FSHD-associated DUX4.
    Homma S; Beermann ML; Yu B; Boyce FM; Miller JB
    Skelet Muscle; 2016 Dec; 6(1):42. PubMed ID: 27906075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engraftment of human induced pluripotent stem cell-derived myogenic progenitors restores dystrophin in mice with duchenne muscular dystrophy.
    He R; Li H; Wang L; Li Y; Zhang Y; Chen M; Zhu Y; Zhang C
    Biol Res; 2020 May; 53(1):22. PubMed ID: 32430065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53-independent DUX4 pathology in cell and animal models of facioscapulohumeral muscular dystrophy.
    Bosnakovski D; Gearhart MD; Toso EA; Recht OO; Cucak A; Jain AK; Barton MC; Kyba M
    Dis Model Mech; 2017 Oct; 10(10):1211-1216. PubMed ID: 28754837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myogenic Progenitors from Mouse Pluripotent Stem Cells for Muscle Regeneration.
    Magli A; Incitti T; Perlingeiro RC
    Methods Mol Biol; 2016; 1460():191-208. PubMed ID: 27492174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscle xenografts reproduce key molecular features of facioscapulohumeral muscular dystrophy.
    Mueller AL; O'Neill A; Jones TI; Llach A; Rojas LA; Sakellariou P; Stadler G; Wright WE; Eyerman D; Jones PL; Bloch RJ
    Exp Neurol; 2019 Oct; 320():113011. PubMed ID: 31306642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinically Advanced p38 Inhibitors Suppress DUX4 Expression in Cellular and Animal Models of Facioscapulohumeral Muscular Dystrophy.
    Oliva J; Galasinski S; Richey A; Campbell AE; Meyers MJ; Modi N; Zhong JW; Tawil R; Tapscott SJ; Sverdrup FM
    J Pharmacol Exp Ther; 2019 Aug; 370(2):219-230. PubMed ID: 31189728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane Repair Deficit in Facioscapulohumeral Muscular Dystrophy.
    Bittel AJ; Sreetama SC; Bittel DC; Horn A; Novak JS; Yokota T; Zhang A; Maruyama R; Rowel Q Lim K; Jaiswal JK; Chen YW
    Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32759720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-Dimensional Human iPSC-Derived Artificial Skeletal Muscles Model Muscular Dystrophies and Enable Multilineage Tissue Engineering.
    Maffioletti SM; Sarcar S; Henderson ABH; Mannhardt I; Pinton L; Moyle LA; Steele-Stallard H; Cappellari O; Wells KE; Ferrari G; Mitchell JS; Tyzack GE; Kotiadis VN; Khedr M; Ragazzi M; Wang W; Duchen MR; Patani R; Zammit PS; Wells DJ; Eschenhagen T; Tedesco FS
    Cell Rep; 2018 Apr; 23(3):899-908. PubMed ID: 29669293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.